Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck Tumors

NCT05758389 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
29
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School